148 related articles for article (PubMed ID: 7708754)
21. Interaction of heparin with human angiogenin.
Soncin F; Strydom DJ; Shapiro R
J Biol Chem; 1997 Apr; 272(15):9818-24. PubMed ID: 9092516
[TBL] [Abstract][Full Text] [Related]
22. Guest-host crosstalk in an angiogenin-RNase A chimeric protein.
Holloway DE; Shapiro R; Hares MC; Leonidas DD; Acharya KR
Biochemistry; 2002 Aug; 41(33):10482-9. PubMed ID: 12173935
[TBL] [Abstract][Full Text] [Related]
23. Mutagenesis of residues flanking Lys-40 enhances the enzymatic activity and reduces the angiogenic potency of angiogenin.
Harper JW; Fox EA; Shapiro R; Vallee BL
Biochemistry; 1990 Aug; 29(31):7297-302. PubMed ID: 1698454
[TBL] [Abstract][Full Text] [Related]
24. Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies.
Holloway DE; Chavali GB; Hares MC; Subramanian V; Acharya KR
Acta Crystallogr D Biol Crystallogr; 2005 Dec; 61(Pt 12):1568-78. PubMed ID: 16301790
[TBL] [Abstract][Full Text] [Related]
25. Identification of functional arginines in human angiogenin by site-directed mutagenesis.
Shapiro R; Vallee BL
Biochemistry; 1992 Dec; 31(49):12477-85. PubMed ID: 1281426
[TBL] [Abstract][Full Text] [Related]
26. Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis.
Shapiro R; Fox EA; Riordan JF
Biochemistry; 1989 Feb; 28(4):1726-32. PubMed ID: 2497770
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the dynamics of bovine and human angiogenin: a molecular dynamics study.
Madhusudhan MS; Vishveshwara S
Biopolymers; 1999 Feb; 49(2):131-44. PubMed ID: 10070263
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
[TBL] [Abstract][Full Text] [Related]
29. The mouse angiogenin gene family: structures of an angiogenin-related protein gene and two pseudogenes.
Brown WE; Nobile V; Subramanian V; Shapiro R
Genomics; 1995 Sep; 29(1):200-6. PubMed ID: 8530072
[TBL] [Abstract][Full Text] [Related]
30. Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis.
Curran TP; Shapiro R; Riordan JF
Biochemistry; 1993 Mar; 32(9):2307-13. PubMed ID: 8095159
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
Kobe B; Deisenhofer J
J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
[TBL] [Abstract][Full Text] [Related]
32. Conformational characterization of human angiogenin by limited proteolysis.
Harper JW; Vallee BL
J Protein Chem; 1988 Aug; 7(4):355-63. PubMed ID: 3151251
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of a pyrimidine dimer-specific excision repair enzyme from bacteriophage T4: refinement at 1.45 A and X-ray analysis of the three active site mutants.
Morikawa K; Ariyoshi M; Vassylyev DG; Matsumoto O; Katayanagi K; Ohtsuka E
J Mol Biol; 1995 Jun; 249(2):360-75. PubMed ID: 7783199
[TBL] [Abstract][Full Text] [Related]
34. Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin.
Hallahan TW; Shapiro R; Strydom DJ; Vallee BL
Biochemistry; 1992 Sep; 31(34):8022-9. PubMed ID: 1380830
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional implications of positive selection at the primate angiogenin gene.
Osorio DS; Antunes A; Ramos MJ
BMC Evol Biol; 2007 Sep; 7():167. PubMed ID: 17883850
[TBL] [Abstract][Full Text] [Related]
36. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
37. Crystallographic studies on the role of the C-terminal segment of human angiogenin in defining enzymatic potency.
Leonidas DD; Shapiro R; Subbarao GV; Russo A; Acharya KR
Biochemistry; 2002 Feb; 41(8):2552-62. PubMed ID: 11851402
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional solution structure of human angiogenin determined by 1H,15N-NMR spectroscopy--characterization of histidine protonation states and pKa values.
Lequin O; Thüring H; Robin M; Lallemand JY
Eur J Biochem; 1997 Dec; 250(3):712-26. PubMed ID: 9461294
[TBL] [Abstract][Full Text] [Related]
39. Dual site model for the organogenic activity of angiogenin.
Hallahan TW; Shapiro R; Vallee BL
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2222-6. PubMed ID: 2006161
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
